TCRT
Alaunos Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.13
+19.01%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$16
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.41
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +89.1%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | — | -$0.41 | — | — |
| May 15, 2026 | — | -$0.59 | — | — |
| Mar 31, 2026 | — | -$0.36 | — | — |
| Nov 14, 2025 | -$4.90 | -$0.55 | Beat 88.78% | — |
| Aug 14, 2025 | -$5.33 | -$0.63 | Beat 88.19% | — |
| May 15, 2025 | -$6.44 | -$0.67 | Beat 89.60% | $2.0K |
| Mar 31, 2025 | -$4.50 | -$0.46 | Beat 89.78% | $4.0K |
| Nov 14, 2024 | -$4.50 | -$0.70 | Beat 84.44% | — |
| Aug 14, 2024 | -$4.50 | -$0.71 | Beat 84.22% | $4.0K |
| May 15, 2024 | -$4.50 | -$1.10 | Beat 75.56% | $1.0K |
| Nov 14, 2023 | -$4.50 | -$6.00 | Miss -33.33% | — |
| Aug 14, 2023 | -$6.00 | -$6.00 | In line | $4.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026